AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

AptarGroup Inc.

RBC Capital analyst Arthur Nagorny maintained a Buy rating on Mattr yesterday and set a price target of C$9.00. The company’s shares closed yesterd...

RBC Capital Reaffirms Their Buy Rating on Mattr (MATR)

In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Atara Biotherapeutics, with a price target of $18.00. Acco...

Mizuho Securities Sticks to Their Buy Rating for Atara Biotherapeutics (ATRA)

Kepler Capital analyst Julian Megias maintained a Buy rating on Atrys Health SA on November 17 and set a price target of €5.00. The company’s share...

Kepler Capital  Sticks to Their Buy Rating for Atrys Health SA (A2T)

Yatra Online Limited ( ($IN:YATRA) ) has provided an announcement. Yatra Online Limited has released the transcript of its earnings conference call...

Yatra Online Limited Releases Q2 FY ’26 Earnings Call Transcript

Mattr Corp. (($TSE:MATR)) has held its Q3 earnings call. Read on for the main highlights of the call. Mattr Corp.’s recent earnings call revealed a...

Mattr Corp. Earnings Call: Growth Amid Challenges

Atkinsrealis ( ($SNCAF) ) has released its Q3 earnings. Here is a breakdown of the information Atkinsrealis presented to its investors. AtkinsRéali...

AtkinsRéalis Reports Strong Q3 2025 Financial Results

Yatra Online Limited (($IN:YATRA)) has held its Q2 earnings call. Read on for the main highlights of the call. The recent earnings call for Yatra O...

Yatra Online Limited Reports Strong Q2 Earnings with Robust Growth

Nature’s Sunshine Products ( ($NATR) ) has released its Q3 earnings. Here is a breakdown of the information Nature’s Sunshine Products presented to...

Nature’s Sunshine Reports Strong Q3 2025 Results

In a report released on November 5, Julian Megias from Kepler Capital maintained a Buy rating on Atrys Health SA, with a price target of €5.00. The...

Water Intelligence ( ($GB:WATR) ) has provided an update. Water Intelligence PLC announced the purchase of 20,000 of its own ordinary shares, execu...

Water Intelligence PLC Executes Share Buyback to Optimize Capital Structure

Astronics (($ATRO)) has held its Q3 earnings call. Read on for the main highlights of the call. Astronics Corporation’s recent earnings call reveal...

Astronics Corp Shines in Strong Earnings Call

Canaccord Genuity analyst James Wood reiterated a Buy rating on Water Intelligence today and set a price target of p500.00. Wood covers the Industr...

Water Intelligence (WATR) Receives a Buy from Canaccord Genuity

AptarGroup received a Hold rating and price target from William Blair analyst Matt Larew today. The company’s shares closed today at $116.01. Accor...

AptarGroup (ATR) was downgraded to a Hold Rating at William Blair

In a report released on October 29, Sabahat Khan from RBC Capital maintained a Buy rating on AtkinsRealis, with a price target of C$115.00. The com...

RBC Capital Sticks to Their Buy Rating for AtkinsRealis (SNCAF)

In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Atricure, with a price target of $50.00. The company’s shares...

Stifel Nicolaus Keeps Their Buy Rating on Atricure (ATRC)

Atricure, Inc. (($ATRC)) announced an update on their ongoing clinical study. Study Overview: AtriCure, Inc. is conducting a multicenter patient re...

AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance

Atricure, Inc. (($ATRC)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled ‘Cryo NerVe Block Extremity...

AtriCure’s Cryoablation Study: A New Frontier in Pain Management

Astron Limited ( ($AU:ATR) ) just unveiled an update. Astron Limited has announced its Annual General Meeting (AGM) scheduled for November 25, 2025...

Astron Limited Announces 2025 Annual General Meeting

Water Intelligence ( ($GB:WATR) ) has shared an announcement. Water Intelligence PLC announced the purchase of 20,000 of its own ordinary shares, e...

Water Intelligence PLC Announces Share Buyback and Voting Rights Update

An update from Astronics ( ($ATRO) ) is now available. On October 22, 2025, Astronics Corporation announced the establishment of a new $300 million...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ATR	$121.42	+2.40%	224.05K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ATR	$121.42	+2.4%	224.05K
3
4
5
6

ATR

ATR

Get AptarGroup Inc. Data in Excel

Get AptarGroup Inc. Data in Excel